DFT Calculations and In silico Study of Chlorogenic, Ellagic and Quisqualic acids as Potential Inhibitors of SARS-CoV-2 Main Protease Mpro

被引:6
|
作者
Shahab, Siyamak [1 ,2 ,3 ]
Kaviani, Sadegh [4 ]
Sheikhi, Masoome [5 ]
Almodarresiyeh, Hora Alhosseini [6 ]
Al Saud, Sultan [1 ,3 ]
机构
[1] Belarusian State Univ, ISEI BSU, Minsk, BELARUS
[2] Natl Acad Sci Belarus, Inst Phys Organ Chem, 13 Surganov Str, Minsk 220072, BELARUS
[3] Natl Acad Sci Belarus, Inst Chem New Mat, 36 Skarina Str, Minsk 220141, BELARUS
[4] Ferdowsi Univ Mashhad, Fac Sci, Dept Chem, Mashhad, Razavi Khorasan, Iran
[5] Islamic Azad Univ, Gorgan Branch, Young Researchers & Elite Club, Gorgan, Golestan, Iran
[6] Meybod Univ, Sch Engn, Dept Mat Sci & Engn, Meybod 8961699557, Yazd, Iran
来源
关键词
SARS-CoV-2 main protease M-pro; DFT; molecular docking; chlorogenic; Ellagic and Quisqualic acids; pharmacokinetic properties; COFFEE; METABOLITES; DERIVATIVES; DISCOVERY; TRANSPORT; UV/VIS; HUMANS;
D O I
10.33263/BRIAC121.061073
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
In the present work, at first, density functional theory calculations were performed to investigate the molecular structure of the Chlorogenic, Ellagic, and Quisqualic acids by CAM-B3LYP/MidiX level of theory. A detail of quantum molecular descriptors of the title compounds such as ionization potential (IP) and Electron Affinities (EA), Hardness (eta), Softness (S), Electronegativity (mu), Electrophilic Index (omega), Electron Donating Power (omega-), Electron Accepting Power (omega+) and Energy Gap (Eg) have been calculated. Pharmacokinetic properties of the title compounds and their bioactivity were investigated. In the following, a molecular docking study was carried out to screen for an effective available compound that may work as a strong inhibitor for the SARS-CoV-2 main protease Mpro. The binding energy between SARS-CoV-2 main protease Mpro and title organic acids showed a good binding affinity. Therefore, the Chlorogenic, Ellagic, and Quisqualic acids can be used for potential application against the SARS-CoV-2 main protease Mpro.
引用
收藏
页码:61 / 73
页数:13
相关论文
共 50 条
  • [21] In-silico drug repurposing for targeting SARS-CoV-2 main protease (Mpro)
    Sharma, Shilpa
    Deep, Shashank
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (07): : 3003 - 3010
  • [22] In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro SARS-CoV-2
    Baby, Krishnaprasad
    Maity, Swastika
    Mehta, Chetan
    Suresh, Akhil
    Nayak, Usha Y.
    Nayak, Yogendra
    PHARMACEUTICAL SCIENCES, 2020, 26 : S52 - S62
  • [23] In vitro and in silico studies of SARS-CoV-2 main protease Mpro inhibitors isolated from Helichrysum bracteatum
    Wahab, Gehad Abdel
    Aboelmaaty, Walaa S.
    Lahloub, Mohamed Farid
    Sallam, Amal
    RSC ADVANCES, 2022, 12 (29) : 18412 - 18424
  • [24] In silico screening of potential antiviral inhibitors against SARS-CoV-2 main protease
    Palanisamy, Kandhan
    Maiyelvaganan, K. Rudharachari
    Kamalakannan, Shanmugasundaram
    Thilagavathi, Ramasamy
    Selvam, Chelliah
    Prakash, Muthuramalingam
    MOLECULAR SIMULATION, 2023, 49 (02) : 175 - 185
  • [25] Casiopeinas® as SARS-CoV-2 main protease (Mpro) inhibitors: a combined DFT, molecular docking and ONIOM approach
    Reina, Miguel
    Gabriel Talavera-Contreras, Luis
    Figueroa-DePaz, Yeshenia
    Ruiz-Azuara, Lena
    Felipe Hernandez-Ayala, Luis
    NEW JOURNAL OF CHEMISTRY, 2022, 46 (26) : 12500 - 12511
  • [26] In silico study of the interactions of Pilocarpus microphyllus imidazolic alkaloids with the main protease (Mpro) of SARS-CoV-2
    de Sa, Ezio R. A.
    Costa, Allan N.
    Costa, Rayla K. M.
    Souza, Janilson L.
    Ramos, Ricardo M.
    Lima, Francisco das C. A.
    MOLECULAR SIMULATION, 2021, 47 (01) : 74 - 87
  • [27] Computational investigation of natural compounds as potential main protease (Mpro) inhibitors for SARS-CoV-2 virus
    Patel, Chirag N.
    Jani, Siddhi P.
    Modi, Krunal M.
    Kumar, Yogesh
    COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 151
  • [28] Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV-2 Mpro)
    Azevedo, Pedro Henrique R. de A.
    Camargo, Priscila G.
    Constant, Larissa E. C.
    Costa, Stephany da S.
    Silva, Celimar Sinezia
    Rosa, Alice S.
    Souza, Daniel D. C.
    Tucci, Amanda R.
    Ferreira, Vivian N. S.
    Oliveira, Thamara Kelcya F.
    Borba, Nathalia R. R.
    Rodrigues, Carlos R.
    Albuquerque, Magaly G.
    Dias, Luiza R. S.
    Garrett, Rafael
    Miranda, Milene D.
    Allonso, Diego
    Lima, Camilo Henrique da S.
    Muri, Estela Maris F.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [29] Computational Investigation on Natural Quinazoline Alkaloids as Potential Inhibitors of the Main Protease (MPro) of SARS-CoV-2
    Jana, Abhisek
    Roy, Tarun
    Layek, Sarbajit
    Ghosal, Subhas
    Banerjee, Deb Ranjan
    JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2022, 21 (01): : 65 - 82
  • [30] Identification of antiviral phytochemicals from cranberry as potential inhibitors of SARS-CoV-2 main protease (Mpro)
    Pillai, U. Jisha
    Cherian, Lucy
    Taunk, Khushman
    Iype, Eldhose
    Dutta, Mainak
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 261